Tozinameran (Pfizer, BioNTech) and Elasomeran (Moderna) Efficacy in COVID-19—A Systematic Review of Randomised Controlled Trial Studies

Background: The objective of this research was to test the efficacy and safety profile of tozinameran (30 μg, BNT162b2, Pfizer, BioNTech) and elasomeran (100 μg, mRNA-1273, Moderna) in COVID-19 prevention in ≥16-year-old patients vaccinated with two doses. Methods: A meta-analysis of the literature...

Descripción completa

Detalles Bibliográficos
Autores principales: Ratajczak, Piotr, Banach, Zuzanna, Kopciuch, Dorota, Paczkowska, Anna, Zaprutko, Tomasz, Krawczyk, Józef, Maciuszek-Bartkowska, Barbara, Kus, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252750/
https://www.ncbi.nlm.nih.gov/pubmed/37297673
http://dx.doi.org/10.3390/healthcare11111532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252750/
https://www.ncbi.nlm.nih.gov/pubmed/37297673
http://dx.doi.org/10.3390/healthcare11111532

Ejemplares similares